| Sep 30 |
Akero Therapeutics to Present at the H.C. Wainwright 8th Annual MASH Virtual Conference
|
| Sep 20 |
Akero Therapeutics: Good Candidate For The MASH Basket
|
| Sep 12 |
Oxford Industries Reports Weak Results, Joins Viper Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
|
| Sep 12 |
Wellington Management Group LLP's Strategic Acquisition in Akero Therapeutics Inc
|
| Sep 9 |
Akero Therapeutics Announces First Patient Dosed in Phase 3 SYNCHRONY Outcomes Study of Efruxifermin in Patients with Compensated Cirrhosis Due to MASH
|
| Sep 5 |
Akero Therapeutics, Inc. (AKRO): This Small-Cap Healthcare Stock Is A Good Buy Right Now
|
| Aug 28 |
Akero Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
|
| Aug 9 |
Amicus (FOLD) Up as Q2 Earnings & Sales Top, '24 View Updated
|
| Aug 9 |
Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down
|
| Aug 9 |
Akero Therapeutics GAAP EPS of -$0.81 beats by $0.08
|
